Table of Contents

July 1, 2023; Volume 64,Issue 7

  1. Gafita, Andrei

    1. PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
      PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
      Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1024-1029; DOI: https://doi.org/10.2967/jnumed.122.265242

  2. Galldiks, Norbert

    1. Hybrid 18F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors
      Norbert Galldiks and Karl-Josef Langen
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1093-1094; DOI: https://doi.org/10.2967/jnumed.123.265647

  3. Gambhir, Sanjay

    1. Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
      Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1001-1008; DOI: https://doi.org/10.2967/jnumed.123.265594

  4. Gauger, Andrew

    1. Hybrid <sup>18</sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Open Access
      Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins and Michael C. Veronesi
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.122.265149

  5. Gear, Jonathan I.

    1. The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
      Open Access
      The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
      Jan Taprogge, Carla Abreu, Siraj Yusuf, Gemma Ainsworth, Rachel H. Phillip, Jonathan I. Gear, Rebecca Gregory, Francesca Leek, Iain Murray, Amy B. Coulson, Sarah R. Brown, Yong Du, Kate Newbold, Jonathan Wadsley and Glenn D. Flux
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1125-1130; DOI: https://doi.org/10.2967/jnumed.122.264913

  6. Geistlich, Susanne

    1. <sup>161</sup>Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of <sup>161</sup>Tb into the Clinic
      Open Access
      161Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of 161Tb into the Clinic
      Chiara Favaretto, Pascal V. Grundler, Zeynep Talip, Stefan Landolt, Lebogang Sepini, Ulli Köster, Cristina Müller, Roger Schibli, Susanne Geistlich and Nicholas P. van der Meulen
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1138-1144; DOI: https://doi.org/10.2967/jnumed.122.265268

  7. Giesel, Frederik L.

    1. PSMA-GCK01: A Generator-Based <sup>99m</sup>Tc/<sup>188</sup>Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
      Open Access
      PSMA-GCK01: A Generator-Based 99mTc/188Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
      Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn and Clemens Kratochwil
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1069-1075; DOI: https://doi.org/10.2967/jnumed.122.264944

  8. Grafe, Hong

    1. Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
      Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass Microspheres
      Masao Watanabe, Hong Grafe, Jens Theysohn, Benedikt Schaarschmidt, Johannes Ludwig, Leonie Jochheim, Matthias Jeschke, Hartmut Schmidt, Wolfgang P. Fendler, Alexandros Moraitis, Ken Herrmann, Kelsey L. Pomykala and Manuel Weber
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1102-1108; DOI: https://doi.org/10.2967/jnumed.122.264996

  9. Graham, Michael M.

    1. Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
      Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1001-1008; DOI: https://doi.org/10.2967/jnumed.123.265594

  10. Graner, Brian

    1. Hybrid <sup>18</sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Open Access
      Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins and Michael C. Veronesi
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.122.265149
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue